
VRTX vs GSK
$VRTX vs $GSK head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
VRTX vs GSK: trend, levels and the market
One year to 2026-11-19, against the S&P 500 (+8.8%). Split-adjusted daily closes.
- ·GSK is the weaker of the two on trend, below both its 50- and 200-day averages, while VRTX has held above one of them.
- ·Only VRTX beat the market over the past year, by 14.7%, while GSK trailed the S&P 500 at +8.8% by 5.3%.
- ·VRTX has support 4.1% below at $498.79; GSK has no tested support within 35% under its price.
- ·VRTX is within 2.3% of resistance at $532.20, a price where it has stalled before.
Support and resistance are daily prices the stock has turned at three or more times, within 35% of the price. The loading zone is the nearby price where the heaviest volume traded. These describe where a stock has been, not where it will go. Not investment advice.
VRTX vs GSK: the quick read
- ·VRTX is the larger company by market cap ($136.01B vs $98.26B).
- ·VRTX has been more active on our scanner (100 vs 73 alerts in 30 days).
- ·VRTX has the smaller float (253.5M vs 2.00B), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·GSK trades at a small fraction of the other's share price, so position sizing and the size of a "normal" move differ a lot between them.
- ·Both stay busy on our scanner, 100 and 73 unusual-volume alerts over 30 days, so neither is the quiet one here.
- ·They are closely matched in size, within 38% of each other on market cap, which makes the rest of this table the interesting part.
- ·GSK pays a dividend and VRTX does not, which usually means one is being held for income and the other for the move.
Objective differences only. Not investment advice.
Watching VRTX or GSK? Get each morning’s movers by email
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing VRTX and GSK on TheDesperateTrader.
- Is VRTX or GSK the better stock?
- "Better" depends on your goal, and these two are not alike. VRTX is the larger company by market cap ($136.01B vs $98.26B). VRTX has been more active on our scanner (100 vs 73 alerts in 30 days). VRTX has the smaller float (253.5M vs 2.00B), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between VRTX and GSK?
- The differences that matter: they are not in the same business - VRTX is pharmaceutical preparations and GSK is pharmaceutical preparations; they are similar in size ($136.01B vs $98.26B); they trade at very different share prices ($520.06 vs $47.77); VRTX sits at 69% of its 52-week range against 12% for GSK; only GSK pays a dividend; our scanner flagged VRTX 100 times in the last 30 days against 73 for GSK. Everything above is measured from the latest completed session and SEC filings.
- Which of VRTX and GSK is more active right now?
- Right now VRTX is at about 0.9x its normal volume and GSK is at about 0.5x, so VRTX is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is VRTX or GSK in the stronger trend?
- VRTX is below its 50-day average of $522.72 and above its 200-day average of $484.59; GSK is below its 50-day average of $49.32 and below its 200-day average of $52.31. VRTX leads 5 of the 5 measures on this page (1 year, vs S&P 500, 3 months, 1 month, trend). A trend is where a stock has been, not a forecast, and nothing here is investment advice.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading VRTX or GSK? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore VRTX and GSK comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.